VAERS Explorer
Back to explore

Report #2878388

Received Dec 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
60 yrs
State
IL
Recovered
Unknown
Vaccinated
Dec 15, 2025
Onset
Dec 15, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKGJ952—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

Shingrix administered ventrogluteal instead on the deltoid; This non-serious case was reported by a other health professional via call center representative and described the occurrence of vaccine administered at inappropriate site in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number GJ952, expiry date 25-APR-2027) for prophylaxis. On 15-DEC-2025, the patient received Shingrix. On 15-DEC-2025, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: Shingrix administered ventrogluteal instead on the deltoid). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 15-DEC-2025 The vaccine administration facility was the same as primary reporter.